Coronary artery dilation and left ventricular hypertrophy do not predict morbidity in children with sickle cell

Mark C Johnson1, Micean J Johnikin, Joshua C Euteneuer

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Washington University School of Medicine/St. Louis Children's Hospital, St. Louis, Missouri.

Pediatric Blood & Cancer
|September 30, 2014
PubMed

Insights

Coronary artery dilation (CAD) and left ventricular hypertrophy (LVH) are common in children with sickle cell disease (SCD). However, these findings do not predict future hospitalizations or intensive care unit admissions.

Area of Science:

  • Cardiology
  • Pediatrics
  • Hematology

Background:

  • The clinical significance of coronary artery dilation (CAD) and left ventricular hypertrophy (LVH) in pediatric sickle cell disease (SCD) is not well understood.
  • Existing research has not established a clear link between these cardiac abnormalities and patient morbidity.

Purpose of the Study:

  • To investigate the prevalence of CAD and LVH in children with SCD.
  • To determine if CAD and LVH predict future hospitalizations or intensive care unit (ICU) admissions in this population.

Main Methods:

  • A retrospective cohort study compared 101 children with SCD to 93 healthy African-American children.
  • Echocardiography was used to assess CAD and LVH.
  • Morbidity was measured by hospital days, number of admissions, and ICU admissions over a median follow-up of 6.1 years.

Main Results:

  • Left ventricular hypertrophy (LVH) was present in 46% of children with SCD and inversely related to age.
  • Prevalence of coronary artery dilation (CAD) was 49% for the left main coronary artery (LMCA), 29% for the left anterior descending (LAD), and 6% for the right coronary artery (RCA).
  • Neither CAD nor LVH predicted subsequent ICU admission, hospital days, or number of hospital admissions. They were also not associated with vaso-occlusive pain, acute chest syndrome, or cerebrovascular accident.

Conclusions:

  • LVH and CAD are frequent findings in children with SCD.
  • These cardiac abnormalities do not appear to be associated with increased risk for future hospital or ICU admissions in pediatric SCD patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
775
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.1K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K